Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis a randomized clinical trial
Richard K. Burt Roumen Balabanov; Joachim Burman; Basil Sharrack; John A Snowden; Maria Carolina Oliveira; Jan Fagius; John Rose; Flavia Nelson; Amilton Antunes Barreira; Kristina Carlson; Xiaoqiang Han; Daniela Moraes; Amy Morgan; Kathleen Quigley; Kimberly Yaung; Regan Buckley; Carri Alldredge; Allison Clendenan; Michelle A Calvario; Jacquelyn Henry; Borko Jovanovic; Irene B Helenowski
Jama Chicago v. 321, n. 2, p. 165-174, 2019Chicago 2019
Localização: FMRP - Fac. Medicina de Ribeirão Preto (pcd 3005062 Estantes Deslizantes )(Acessar)